Croda International Plc (LSE:CRDA) agreed to acquire Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. (KOSE:A336370) for KRW 350 billion on February 3, 2023. The acquisition is subject to regulatory approval. Lazard & Co., Limited acted as financial advisor to Croda International Plc (LSE:CRDA).
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16,790 KRW | +3.77% | +4.94% | +26.72% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.72% | 916M | |
+12.70% | 109B | |
-2.56% | 30.15B | |
+4.87% | 20.81B | |
-11.50% | 18.73B | |
+19.36% | 16.78B | |
-13.00% | 16.43B | |
+10.44% | 13.51B | |
-1.71% | 10.88B | |
+4.18% | 8.7B |
- Stock Market
- Equities
- A336370 Stock
- News Solus Advanced Materials Co., Ltd.
- Croda International Plc agreed to acquire Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. for KRW350 billion.